Our mission is to provide innovative technology tailored with an excellent Monitoring Service and by that to elevate patient quality of care and providing the Physician with the best tools to practice best service.
Build value by making strategic acquisitions of businesses that have innovative solutions and services for the healthcare market.
Bring innovation and improved efficiency to achieve greater value in clinical diagnostics patient adherence and better outcomes .
Provide advanced diagnostic tools for more precise disease detection and management resulting in better health services .
Deliver patient centric systems by moving inpatient to outpatient care signaling their needs and wants resulting in better quality of car.
Paul Danner joined CB Scientific in October 2021 as Chairman of the Board of Directors. He is skilled at successfully marketing service offerings, securing product placement, increasing market share, and growing revenue while affiliated with an array of Fortune 100 organizations, mid-market companies, and start-up ventures.
As a senior business leader, Mr. Danner has served three Nasdaq-listed companies as the senior corporate executive. Additionally, he has acquired extensive Board of Director expertise through six separate appointments totaling more than twenty-five years with three Nasdaq and OTCQB listed companies including Chairman, Corporate Secretary, and Audit Committee assignments, as well as two development-stage ventures and one not-for-profit enterprise.
Mr. Danner served as a Naval Aviator flying the F-14 Tomcat, and subsequently as an Aerospace Engineering Duty Officer supporting the Naval Air Systems Command, for 8 years on active duty plus 22 years with the reserve component of the United States Navy. He retired from the Navy in 2009 with the rank of Captain. Mr. Danner earned a BS degree in Business Finance from Colorado State University, and he holds an MBA from the Strome College of Business at Old Dominion University.
Charles Martin has held positions in sales, marketing, and executive management in the non-invasive Ambulatory ECG marketplace for more than 35 years. His extensive experience includes working in direct product capital equipment and software sales both domestically and internationally, management and direction of IDTF remote cardiac monitoring services, and oversight of international distributor networks in Europe, Asia, and the Middle East. His career in the cardiac medical market began with Oxford Medical in 1985 where he sold the first “real-time” Holter analysis software system and recording devices offered in the US in a four-state Midwest territory.
He was promoted to Eastern Regional Sales Manager for the company in 1987. Career highlights include Regional Sales Manager for Spacelabs (Holter, Ambulatory Blood Pressure), National Sales Manager and Director of Sales for Instromedix (Cardiac Event Monitoring – King of Hearts), VP Sales and Marketing for CardioComm Solutions (GEMS Acquisition ECG Software for Event & Pacer TTM follow-up), and VP of Business Development with Biomedical Systems (IDTF Services, Holter, AEM, MCT). From 2014 to 2018, Chip worked as the Senior Director of Global Sales for BioTelemetry Inc. a widely recognized leading provider of remote cardiac monitoring diagnostic services in the US that is publicly traded on the NASDAQ exchange (BEAT). He held the position of SVP of Sales and Marketing for My-Cardia (USA) Inc. from 2018 to 2019 and was promoted to CEO and President of Prevent Health Care International Corporation in August 2019, assuming the same roles now at CB Scientific, Inc., as well as Director.
Ms. Martellaro began her career with Arthur Andersen & Co. before progressing quickly to positions of ever-increasing responsibility with Jones Intercable, Qwest Communications International, and Dex Media, a $1.6 Billion, NYSE-listed private equity portfolio company, and others. Since launching her independent consulting practice, Ms. Martellaro has advised clients in the Construction, Financial, Healthcare, Industrials, Professional Services, Real Estate, and Technology sectors on strategic, financial, and operational improvements.
Robert Kelley has extensive experience with high-growth companies from VC-backed high-technology startups to large public corporations in roles including founder, CTO/VP Engineering, EVP Strategic Marketing, Corporate Development. He has led multiple first-mover product teams developing novel enterprise technologies from high-performance computers, broadband networks, and storage, to enterprise software from manufacturing/ERP, financial/accounting, and data warehousing/BI. His graduate studies and teaching includes Computer Science, Linguistics and Artificial Intelligence, Marketing, and Analytics. Rob is a Chartered Financial Analyst (CFA). Rob uses analytics and his technology experience to inform marketing strategy, evaluate emerging technologies, and understand the economic value for customers.
James Ott held several senior leadership positions in his twenty-eight-year career in the Ambulatory ECG and Clinical Research Trials arena. Upon earning his Master of Science in Biomedical Engineering at Marquette University in 1991, Jim joined Biomedical System in St. Louis, MO in 1992 as a Product Manager where he coordinated the design, development, and marketing efforts of their cardiac diagnostic software platform lines. In this role, he facilitated regulatory submissions and regulatory inspection for the product line to include the creation of multiple Original Equipment Manufacturer (OEM) channels with major medical device manufacturers both domestically and internationally. He was promoted in 2000 to President of Biomedical Systems Cardiology Division where he managed all aspects of their Independent Diagnostic Testing Facility (IDTF) to include international direct and distributor capital equipment sales, IDTF cardiology lab staffing, technology, sales and marketing, customer service, and reimbursement and regulatory activities. During this time he managed the design, development, and implementation of the company’s internet-based Holter data and report transfer platform (Data Exchange), their internet-based Holter analysis platform (MyHolter.com), and their Mobile Cardiac Telemetry (MCT) platform – the TruVue® Wireless ECG Monitoring System. Jim was an integral part of successful US patent submissions and granted approvals for all three of these applications in 2004, 2005, and 2013 where he is listed as one of the inventors.
Zig Lambo holds a BS degree in General Engineering and an MBA in Finance and Marketing; and has been involved in the public markets since 1970. He was a securities analyst, broker, and merger and acquisition specialist in the 1970s and 1980s, including initiating the acquisition of Codex Corporation by Motorola in 1977. Zig was an internationally recognized analyst and consultant on mining companies and has been involved in a number of public and private mining-related companies over the years as an investor and officer. He has formed and taken three companies public, including Net:X America Inc., which became CB Scientific in 2016. He continues to be active in various public and private venture projects in technology and resource development in the U.S., Canada, and Asia.
Mr. Hesse founded his investment banking firm, Swartwood, Hesse Inc., in 1980 and later formed the Dorchester Group, LLC. Complimenting these initiatives is a platform of 40 years of transactional experience in venture capital, equity, debt private placements, corporate financing, and valuation advisory services. Mr. Hesse was CEO of Natural Health Trends (NASDAQ NHTC), directing the business and financial operations throughout China, Korea, and Russia. Mr. Hesse was also president of a Korean-based immigration service company and directorships on many publicly traded US corporations.
With an international reach and the ability to serve local and abroad companies, MaloneBailey, LLP proudly delivers audit, tax, and consulting services to public and private companies, both small and mid-market. The firm is an established market leader in the delivery of audit services to publicly traded clients, with a substantial number of U.S., listed registrants as clients, including NYSE, NASDAQ, and OTC listed companies. In addition, MaloneBailey’s team of experienced accounting professionals offers a range of services under AICPA, SEC, PCAOB, IRS, and CPAB rules, as they apply.